European advisory group rescinds authorization for omega-3 fatty acid meds for use after heart attacks

|By:, SA News Editor

Citing the lack of evidence that they work for the indication, the European Medicines Agency's advisory group CHMP has withdrawn its authorization for the use of omega-3 fatty acid medications to prevent further heart and blood vessel problems in heart attack patients. The meds have been approved in the EU since 2000 at a dose of 1g/day for this indication.

The medications remain approved for reducing triglyceride levels.

Related tickers: (AMRN -1.9%)(MTNB +0.6%)(NEPT -0.7%)

Subscribe for full text news in your inbox